Martingale Asset Management L P Acquires 15,400 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Martingale Asset Management L P grew its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 1,100.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,800 shares of the medical instruments supplier's stock after purchasing an additional 15,400 shares during the quarter. Martingale Asset Management L P owned about 0.07% of ICU Medical worth $2,607,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in ICUI. Norges Bank acquired a new stake in shares of ICU Medical in the 4th quarter worth about $40,151,000. State Street Corp raised its holdings in shares of ICU Medical by 9.3% in the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock valued at $165,384,000 after purchasing an additional 77,506 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of ICU Medical in the fourth quarter valued at approximately $10,003,000. JPMorgan Chase & Co. increased its holdings in shares of ICU Medical by 7.4% during the fourth quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier's stock worth $109,920,000 after buying an additional 49,108 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock worth $99,687,000 after purchasing an additional 48,106 shares during the period. 96.10% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently commented on ICUI. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. Raymond James set a $97.00 target price on shares of ICU Medical in a report on Wednesday, March 12th. Finally, StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a research report on Wednesday. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, ICU Medical presently has a consensus rating of "Buy" and an average price target of $168.67.

ICU Medical Stock Up 0.1 %

ICUI traded up $0.10 during trading on Wednesday, reaching $139.74. 20,264 shares of the stock traded hands, compared to its average volume of 268,320. The stock has a market cap of $3.43 billion, a price-to-earnings ratio of -30.58 and a beta of 0.86. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The stock's 50-day simple moving average is $147.50 and its two-hundred day simple moving average is $160.47. ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.26.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.